Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

MiniMed Stock Surges 11% to $13.69 After Strong Q4 Results and Bullish 2027 Outlook

Published

on

Legend Biotech Shares Surge 20% on Promising ASCO Data for

NEW YORK — MiniMed Group Inc. shares jumped more than 11% on Wednesday, reaching $13.69 as investors responded positively to the diabetes technology company’s strong fourth-quarter and full-year 2026 financial results, along with an optimistic outlook for the coming year.

The medical device firm, which was spun out from Medtronic earlier this year, reported robust revenue growth and progress in its automated insulin delivery systems. The gains pushed MiniMed’s market capitalization higher amid renewed interest in diabetes care stocks following positive clinical data and product pipeline updates.

For the full fiscal year 2026, MiniMed delivered revenue of approximately $3.1 billion, reflecting solid demand for its MiniMed 780G automated insulin delivery system and related sensors. The company highlighted strong adoption of its integrated pump and continuous glucose monitoring solutions, particularly in key markets across North America and Europe.

In the fourth quarter, MiniMed posted revenue growth driven by higher sales of consumables and new system launches. While the company still reported a net loss, operational improvements and cost management helped narrow the deficit compared to prior periods. Management emphasized expanding gross margins and operational efficiency as key priorities following the spin-off.

Advertisement

MiniMed also announced plans to expand its sensor portfolio through a collaboration with Abbott for integrated dual glucose-ketone sensors. This development is expected to strengthen its competitive position in the growing automated insulin delivery market.

Analysts have largely welcomed the results. Several firms maintained Buy ratings on the stock, citing MiniMed’s leadership in insulin pump technology and potential for market share gains as diabetes prevalence continues rising globally. Average price targets remain well above current levels, with some analysts highlighting the company’s attractive valuation post-spin-off.

The diabetes technology sector has seen increased attention in 2026 as new automated systems and sensor innovations improve patient outcomes. MiniMed’s MiniMed 780G system, which automatically adjusts insulin delivery every five minutes based on real-time glucose readings, has been a key growth driver. Recent regulatory approvals and real-world data presentations at major medical conferences have supported adoption.

As an independent company, MiniMed aims to operate with greater agility to innovate and capture market share. The spin-off from Medtronic, completed in March 2026, has allowed focused investment in diabetes-specific technologies while maintaining access to broader healthcare expertise.

Advertisement

Challenges remain in the competitive landscape. MiniMed faces rivals including Dexcom, Insulet and Tandem Diabetes Care. Pricing pressure and reimbursement dynamics in key markets also require careful navigation. However, the company’s comprehensive platform — combining pumps, sensors, algorithms and support services — provides a differentiated offering.

MiniMed’s leadership has expressed confidence in its growth trajectory. The company provided fiscal 2027 guidance that projects continued revenue expansion and margin improvement. Management highlighted pipeline advancements, including next-generation systems and expanded indications for existing products.

Investor sentiment appears to be shifting positively after a period of post-IPO volatility. Shares debuted in March 2026 at $20 but faced pressure amid broader market conditions before stabilizing in recent weeks. Wednesday’s surge reflects renewed optimism following the earnings release.

The global diabetes market continues expanding due to rising prevalence, aging populations and greater awareness of advanced management tools. MiniMed is well-positioned to benefit, with a strong commercial footprint in approximately 80 countries and over 640,000 insulin pump users as of late 2025.

Advertisement

Analysts project mid-teens revenue growth in coming years if execution remains strong. Key catalysts include further regulatory approvals, successful product launches and potential partnerships. The company’s focus on integrated solutions aligns with trends toward automated, user-friendly diabetes management.

For investors, MiniMed represents exposure to a critical healthcare need with technological leadership. While the stock carries typical risks associated with medical device companies — including regulatory hurdles, reimbursement changes and competition — its established market position and innovation pipeline provide a foundation for potential long-term growth.

Trading volume was elevated on Wednesday as the earnings news circulated. The stock’s beta suggests sensitivity to broader healthcare and technology sector movements, but fundamentals appear supportive following the latest report.

MiniMed continues investing in research and development to maintain its competitive edge. Recent data presentations at the American Diabetes Association Scientific Sessions highlighted real-world performance of its systems, showing improved time-in-range metrics for patients.

Advertisement

The company’s transition to standalone status has involved operational streamlining and focused strategy development. Leadership changes and board additions, including experienced Medtronic executives, aim to strengthen governance and commercial execution.

As the trading day progressed, MiniMed shares held most of their gains, trading around $13.69. The move underscores investor appetite for healthcare innovation stories with clear growth drivers.

Broader market context remains supportive for medical technology stocks with strong clinical value. While economic uncertainty persists, demand for diabetes management solutions tends to be relatively resilient due to chronic disease prevalence.

Looking ahead, MiniMed will focus on executing its 2027 plan while advancing its product pipeline. Successful commercialization of new sensors and system enhancements could drive further upside. Analysts will closely monitor quarterly progress and competitive dynamics.

Advertisement

For patients, MiniMed’s technologies represent meaningful improvements in daily diabetes management. Automated systems reduce burden and improve outcomes, aligning with the company’s mission to make every day better for people with diabetes.

MiniMed’s performance on Wednesday highlights the potential rewards of innovation in healthcare technology. As the company establishes itself as an independent entity, sustained execution will be key to realizing long-term shareholder value in a growing global market.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Form 13D/A Repay Holdings Corp For: 3 June

Published

on


Form 13D/A Repay Holdings Corp For: 3 June

Continue Reading

Business

Bernie Sanders proposes taking 50% of stock from OpenAI, xAI, others

Published

on

Bernie Sanders proposes taking 50% of stock from OpenAI, xAI, others

Democratic socialist Sen. Bernie Sanders, I-Vt., is arguing that the federal government should establish a sovereign wealth fund that’s financed by taking possession of half of the stock in AI giants like OpenAI, Anthropic and xAI, among others.

Sanders wrote an op-ed in The New York Times on Sunday that AI companies built and trained their models using the creative work of millions of people to inform generative AI tools, mostly without receiving permission from the creators or compensating them.

Advertisement

He explained that those creative works have “essentially been stolen by some of the wealthiest people in the world. It’s time for us to reclaim it.”

“Since AI is built on the collective knowledge of humanity, the wealth it generates must benefit humanity,” Sanders wrote, rather than benefiting the founders of leading AI companies or “venture capitalists in Silicon Valley or money managers on Wall Street who undoubtedly see AI as the next great wealth-extracting machine.”

BERNIE SANDERS WARNS OF ‘THE MOST TRANSFORMATIVE ECONOMIC REVOLUTION IN THE HISTORY OF THIS COUNTRY’

Senator Bernie Sanders speaking

Sen. Bernie Sanders, I-Vt., is calling for an AI sovereign wealth fund with large stakes in leading U.S.-based AI companies. (Nathan Posner/Anadolu via Getty Images)

Sanders explained that he’s planning to introduce legislation that will be called the American AI Sovereign Wealth Fund Act, which would impose a one-time 50% tax payable with the stock of leading AI companies like OpenAI, Anthropic, xAI and others.

Advertisement

The senator said the bill would give the public “a direct role in determining the future of this technology,” if his legislation were enacted.

“No longer would the future of AI and the transformation of human life that it will bring be dictated by a handful of Big Tech oligarchs,” Sanders wrote. “The federal government would have the power, through its voting shares and an equal representation on each company’s board, to block decisions that hurt our citizens and to push for policies that help them.”

ROWE WARNS OF MASSIVE WORKFORCE SHAKEUP, SAYS SANDERS IS RIGHT: ‘REVOLUTION UNLIKE ANYTHING’ WE’VE SEEN COMING

Elon Musk Sam Altman

Sanders’ bill aims to take large ownership stakes in AI companies founded by “Big Tech oligarchs” like Elon Musk and Sam Altman. (Michael Kovac/Getty Images for Vanity Fair)

He added that the bill would also “guarantee that the trillions of dollars potentially generated by AI are used to improve the lives of all of us – not simply to make the richest people in the world even richer.”

Advertisement

“If the big AI companies continue to grow as rapidly as many analysts expect, then the value of the sovereign wealth fund will grow as well – and the benefits to the American people will grow along with it,” the senator wrote.

Sanders said other sovereign wealth funds, like the one operated by Norway’s government derived from oil revenues, give the government a say in how those resources should be used for the nation rather than allowing oil companies to direct those funds. 

He also noted Alaska’s oil fund as well as state pension systems holding stock in companies as other examples of the role the government can play.

ELON MUSK CALL HIMSELF A ‘MAKER,’ SLAMMING POLITICIANS LIKE BERNIE SANDERS: ‘THEY TAKE’

Advertisement
Sen. Bernie Sanders speaks at a

Sen. Bernie Sanders speaks during a “Fight Oligarchy” rally in Orono, Maine, where he warned that artificial intelligence and robotics could replace workers and deepen economic inequality. (Fox News / Fox News)

Sanders’ proposal for the AI sovereign wealth fund to control 50% of the stock in U.S. AI companies goes well beyond the limit imposed by Norway’s sovereign wealth fund, which prohibits the fund from holding more than 10% of the shares in public companies, aside from real estate firms.

Additionally, state pension funds typically hold relatively small amounts of stock in individual companies as the funds tend to diversify their holdings to help safeguard the pensions’ assets.

Under the senator’s proposal, the “billions, if not trillions, of dollars generated by this fund would provide direct payments to the American people. And as the fund generates more and more wealth, the proceeds would be used to ensure that every man, woman and child in our country has a decent and dignified standard of living, including healthcare, education and housing.”

“I recognize that for the government to have a major stake in a company, particularly one for which AI is only part of its business, is complicated. More details – including the specific spending priorities and the mechanics of implementation – will be included in the legislation I unveil in the coming weeks,” Sanders said.

Advertisement

GET FOX BUSINESS ON THE GO BY CLICKING HERE

“But the principle is simple: when a public resource generates wealth, the public should share in that wealth. AI is being built on a public resource far more valuable than oil: the accumulated knowledge, creativity and labor of mankind,” he explained.

Continue Reading

Business

Stock Markets Signal They’re Ready to Absorb Google and Anthropic Capital Raises

Published

on

Stock Markets Signal They’re Ready to Absorb Google and Anthropic Capital Raises

Stock Markets Signal They’re Ready to Absorb Google and Anthropic Capital Raises

Continue Reading

Business

Nestle has big plans for agentic AI

Published

on

Nestle has big plans for agentic AI

Expected to improve shopping experience for consumers.

Continue Reading

Business

SPAC and New Issue ETF (SPCK) Rises 0.72% as Investors Hunt Fresh IPO and Merger Plays in 2026

Published

on

Intel Stock Surges on $14.2B Ireland Fab Buyback as Chipmaker

NEW YORK — The SPAC and New Issue ETF (NASDAQ: SPCK) gained 0.72% on Wednesday morning, climbing to $22.49 as renewed investor interest in special purpose acquisition companies and upcoming initial public offerings lifted sentiment around the specialized fund.

The ETF, which provides targeted exposure to SPACs, pre-IPO companies and newly listed stocks, has attracted attention in 2026 as the market for new issues shows signs of thawing after several years of subdued activity. Trading volume remained solid in morning sessions, reflecting selective buying in a segment that has lagged broader market gains for much of the past two years.

The SPAC and New Issue ETF aims to capture opportunities in companies going public through traditional IPOs or mergers with blank-check companies. Its portfolio typically includes a mix of pre-de-SPAC targets, recent listings and special purpose vehicles still seeking acquisitions. With many high-profile companies choosing to go public in recent quarters, the ETF has offered investors a diversified way to participate in this resurgence without picking individual names.

Market participants pointed to several factors supporting the ETF’s modest advance. Improving macroeconomic conditions, stabilizing interest rates and stronger corporate confidence have encouraged more companies to explore public listings. Investment banks have reported increased IPO pipeline activity, particularly in technology, healthcare and clean energy sectors.

Advertisement

The broader SPAC market has evolved significantly since its peak frenzy in 2020-2021. Many earlier deals faced challenges with performance and regulatory scrutiny, leading to a sharp decline in new formations. However, 2026 has seen a more disciplined approach, with sponsors focusing on stronger targets and clearer paths to value creation. This maturation has helped restore some investor confidence.

Analysts note that SPCK benefits from exposure to both completed mergers and companies in the pre-listing phase. The ETF’s structure allows it to hold positions across various stages of the new issue lifecycle, providing a balanced approach to a historically volatile segment. Its year-to-date performance has been positive but trails major indices, reflecting the cautious return of capital to the space.

Wednesday’s gain came amid a broader rotation in small and mid-cap stocks, where many newly public companies reside. The Russell 2000’s solid performance earlier in the week provided a supportive backdrop for names with recent listings or pending mergers. Investors appear to be positioning for potential catalysts such as major IPOs expected in the second half of 2026.

The ETF holds a diverse basket of holdings, including stakes in companies that have gone public through SPAC mergers in sectors ranging from electric vehicles and biotechnology to fintech and software. Performance has been driven by several successful de-SPAC transactions that delivered strong post-merger results, though others have struggled with integration challenges and market conditions.

Advertisement

Fund managers have emphasized disciplined selection criteria, focusing on companies with proven business models, strong management teams and realistic growth projections. This approach contrasts with the more speculative nature of earlier SPAC waves and has helped the ETF avoid some of the sharp drawdowns seen in the broader sector.

Regulatory developments continue shaping the landscape. The Securities and Exchange Commission has maintained stricter disclosure requirements for SPACs and new listings, aiming to protect investors while allowing viable companies access to public markets. These rules have contributed to higher quality deals reaching the market in 2026.

Institutional interest in the ETF has grown steadily. Pension funds, hedge funds and retail investors seeking exposure to emerging growth stories have increased allocations. The product’s relatively low expense ratio and diversified holdings make it an accessible entry point compared to direct investments in individual SPACs or pre-IPO shares.

Challenges remain for the new issue market. Valuation discipline is critical, as many recent listings have experienced post-debut volatility. Companies must demonstrate sustainable growth and clear competitive advantages to maintain investor support after the initial hype fades. The SPCK ETF attempts to mitigate single-name risk through broad exposure across multiple deals and stages.

Advertisement

Looking ahead, several major IPOs and SPAC transactions are anticipated in coming months. Technology infrastructure, artificial intelligence applications and renewable energy companies are expected to feature prominently. The ETF is well-positioned to capture upside from these potential debuts while maintaining exposure to already-listed former SPACs showing operational progress.

Market strategists suggest the current environment favors selective participation in new issues. With interest rates potentially peaking and economic growth holding steady, conditions appear more supportive for growth-oriented companies seeking public capital. However, caution remains regarding overall market volatility and sector-specific risks.

The SPAC and New Issue ETF has carved out a specialized niche in the investment landscape. By focusing on companies at various stages of going public, it offers a unique risk-reward profile that appeals to investors comfortable with higher volatility in pursuit of potentially outsized returns from emerging leaders.

Performance data shows the ETF has experienced periods of strong gains during active IPO windows, followed by consolidation when deal flow slows. Its 2026 results reflect a gradual recovery in the new issue market rather than the explosive moves seen in previous cycles.

Advertisement

For financial advisors, the ETF provides a convenient tool for clients seeking targeted exposure to IPOs and SPACs without the operational complexities of direct investing. Its daily liquidity and transparent holdings make it suitable for both tactical allocations and longer-term thematic portfolios.

As the trading day continued Wednesday, the SPCK ETF maintained its gains, trading around $22.49. The modest advance reflects measured optimism rather than exuberance, consistent with the more disciplined nature of today’s new issue market.

Broader market context supports cautious participation. Strong corporate earnings in certain growth sectors and steady economic indicators have encouraged companies to move forward with listing plans. Investment bankers report healthier pipelines compared to 2024 and early 2025.

The evolution of SPAC structures, including better alignment of sponsor incentives and longer timelines for deal completion, has improved outcomes for investors. These changes have helped rebuild credibility in the mechanism as a viable path to public markets for quality companies.

Advertisement

Looking further into 2026, analysts expect continued moderate deal flow. Technology and healthcare are likely to lead activity, while consumer and industrial sectors may see selective opportunities. The SPCK ETF’s flexible mandate positions it to adapt across these varying themes.

Investors should approach the segment with realistic expectations. While attractive opportunities exist, not all new issues deliver strong long-term performance. Thorough due diligence and diversified exposure remain essential for success in this space.

The SPAC and New Issue ETF continues to serve as an important vehicle for capturing the excitement and potential of companies entering public markets. Wednesday’s positive performance adds to a constructive tone for the product as market conditions gradually improve for new listings and mergers.

As summer approaches, focus will shift toward upcoming earnings from recently listed companies and potential new filings. These developments will likely influence the ETF’s trajectory in the second half of 2026.

Advertisement

For now, the 0.72% gain to $22.49 reflects steady interest in a segment that has shown renewed vitality. The SPAC and New Issue ETF remains a specialized but increasingly relevant option for investors seeking exposure to the next generation of public companies.

Continue Reading

Business

Norms issued to estimate District Domestic Product

Published

on

Norms issued to estimate District Domestic Product
New Delhi: The statistics ministry on Wednesday released uniform guidelines for estimating district domestic product (DDP), introducing standardised indicators, sector-specific estimation methodologies, and a greater focus on bottom-up data collection under the revised 2022-23 base year.

The guidelines recommend using goods and services tax (GST) collections to estimate economic activity in trade, hotels, and restaurants; Annual Survey of Industries data for organised manufacturing, Annual Survey of Unincorporated Sector Enterprises for informal sector activities and the RBI banking statistics for financial services.

Earlier this year, the ministry of statistics and programme implementation (MoSPI) revised the national gross domestic product base year to 2022-23 from 2011-12.
“The availability of reliable and comparable DDP estimates is expected to support decentralised planning, evidence-based policy formulation, regional development analysis and informed decision-making at the district levels,” the ministry said in a statement The guidelines provide a framework for covering all major sectors of the economy, including agriculture, manufacturing, construction, trade, transport, financial services, public administration, and other services.

Continue Reading

Business

Trump tariffs target 60 countries over failure to ban forced labor imports

Published

on

Trump tariffs target 60 countries over failure to ban forced labor imports

The Trump administration on Tuesday night announced a new plan to impose tariffs on up to 60 trading partners which would face additional import taxes of 10% or 12.5%.

The office of the U.S. Trade Representative (USTR) released a report that found the 60 countries were neglecting to enforce rules prohibiting imported goods made with forced labor, which in turn had a negative impact on American companies. 

Advertisement

It found that 54 countries, including notable trading partners like China, Vietnam, Japan, South Korea and the United Kingdom, failed to impose and enforce a forced labor ban. A further six countries failed to effectively enforce such a ban, including Canada, Mexico and the European Union.

“The failure of our most important trading partners to address the importation of goods made with forced labor is unacceptable,” said Ambassador Jamieson Greer. “This creates a dynamic where American workers are forced to compete globally on an unlevel playing field.”

DHS EXPANDS FORCED LABOR IMPORT BAN TO STEEL, LITHIUM, BLOCKS IN CHINESE GOODS

Jamieson Greer

U.S. Trade Representative Jamieson Greer announced the plans for new forced labor tariffs. (Victor J. Blue/Bloomberg via Getty Images)

“We will no longer tolerate this disparity,” Greer said. “Some trading partners have taken initial steps to prevent the importation of forced labor goods, including through USMCA and commitments in Agreements on Reciprocal Trade.”

Advertisement

“However, each of our trading partners must do more to ensure that trade does not perversely encourage and entrench forced labor,” he added.

For trading partners that have either a ban on forced labor imports, have committed to impose such a prohibition or have imposed a partial regime to prevent the importation of goods made with forced labor, they would have an additional 10% tariff. All other economies would face an additional tariff of 12.5%.

‘FORCED LABOR’: STATE AGS PROBE CHINESE COMPANY TEMU OVER ‘DISTURBING’ BUSINESS PRACTICES

Garment workers in a Cambodian factory

The textile industry is particularly vulnerable to sourcing cotton made with forced labor in China. (Wu Changwei/Xinhua via Getty Images)

USTR’s proposal also includes a mechanism to allow certain volumes of imported apparel and textiles to enter the U.S. at a lower tariff rate. Forced labor is commonly used overseas in producing cotton that’s used in textile products, particularly that which is sourced from the Xinjiang region of China

Advertisement

Federal laws against the use of forced labor ban the importation of cotton made with forced labor into the U.S., including the Uyghur Forced Labor Prevention Act. The law refers to the ethnic Uyghurs who reside in Xinjiang and have faced persecution from the Chinese Communist Party, with many subject to forced labor.

The USTR report notes that nearly all the 60 countries that were subject to the investigation that began in March imported cotton from China in 2021 and 2025. It adds that the complexity of supply chain tracing “makes it difficult for consumers and apparel companies to trace their supply chains all the way to the raw material, particularly as garments produced by third-economy producers would not indicate China as their source.”

AI HELPING REMOVE CHINESE GOODS MADE WITH UYGHUR FORCED LABOR FROM CORPORATE SUPPLY CHAINS

Xinjiang Uyghur Camp

Ethnic Uyghurs in Xinjiang, China, are subject to forced labor and mass internment by the Chinese government. (Greg Baker/AFP via Getty Images)

The 60 countries that were investigated and found to impose or enforce a forced labor import ban imposed an “unreasonable or discriminatory burden” on U.S. commerce, according to the report.

Advertisement

USTR said that “undermines the universal aim of eliminating forced labor; permits firms that avail themselves of forced labor to produce goods at lower cost and therefore distort market conditions for firms that do not use forced labor; undermines that profitability of firms that do not use forced labor; and contributes to the circumvention of existing forced labor import prohibitions.”

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Written comments on the proposal are due by July 6, with the USTR to hold hearings the following day on July 7. Interested parties should submit requests to appear at the hearings, along with a summary of testimony, by June 22.

Advertisement
Continue Reading

Business

Slideshow: New products from Sweets & Snacks 2026

Published

on

Slideshow: New products from Sweets & Snacks 2026

Innovations at the show included new formats and formulations.

Continue Reading

Business

SpaceX to Raise Record $75 Billion in IPO at Fixed $135 Share Price for $1.75 Trillion Valuation

Published

on

MiniMed Stock Surges 11% to $13.69 After Strong Q4 Results

NEW YORK — SpaceX, Elon Musk’s rocket and satellite company, plans to raise a record $75 billion in its initial public offering by fixing the share price at $135, targeting a $1.75 trillion valuation in one of the largest and most unconventional listings in market history.

The company intends to sell 555.6 million shares in an all-primary offering, with proceeds directed toward expanding AI computing resources and its Starlink satellite network. The fixed-price approach breaks from traditional IPO practices, where companies typically set a price range and adjust based on investor demand during roadshows.

SpaceX’s roadshow begins Thursday after preliminary meetings with investors. The debut is expected on Nasdaq under the ticker “SPCX” on June 12, led by underwriters Goldman Sachs, Morgan Stanley, BofA Securities, Citigroup and J.P. Morgan. The plans remain subject to change based on investor feedback.

This move positions SpaceX to lead a wave of major listings, with OpenAI and Anthropic also preparing public debuts that could collectively add nearly $4 trillion in market capitalization. The listing comes after SpaceX merged with Musk’s xAI earlier this year in a deal valuing the rocket business at $1 trillion and xAI at $250 billion.

Advertisement

The fixed $135 price reflects Musk’s signature style of defying convention. “Musk is simply taking a ‘take-it-or-leave-it’ approach which works for his followers and is also sensible given the market conditions and the lack of comparables,” said Weiheng Chen, a senior partner at law firm Wilson Sonsini Goodrich & Rosati.

SpaceX is also planning to allocate up to 30% of the offering to retail investors, an unusually large portion designed to tap into Musk’s dedicated following. Musk himself will be required to hold his shares for 366 days post-IPO, signaling long-term commitment to new shareholders.

The company has no direct public peers, complicating valuation. Morningstar recently estimated SpaceX’s fair value at $780 billion — 48% below the targeted $1.75 trillion — with most of that value attributed to the Starlink satellite communications business. At the proposed valuation and 2025 revenue of $18.67 billion, SpaceX would trade at nearly 94 times trailing revenue.

For context, Rocket Lab trades at 118 times revenue, Palantir at 81 times, and Tesla at roughly 17 times. SpaceX reported a net loss of $4.94 billion in 2025, swinging from a $791 million profit the prior year, so it cannot be evaluated on a price-to-earnings basis.

Advertisement

Starlink remains the primary profit driver, generating most of the company’s revenue and growth. However, two of SpaceX’s three main businesses continue burning cash, with losses widening to $1.27 per share in the first quarter of 2026 from 18 cents a year earlier. Revenue grew to $4.69 billion in the quarter from $4.07 billion previously.

The IPO structure is all-primary, meaning all proceeds go to the company rather than allowing existing shareholders to sell shares. This approach provides SpaceX with substantial capital to fuel ambitious projects, including Starlink expansion and integration with xAI’s artificial intelligence initiatives.

Investor interest is expected to be intense, driven as much by Musk’s track record as by SpaceX’s fundamentals. His success at Tesla has shown an ability to galvanize retail traders and deliver long-term value despite short-term volatility. The upcoming roadshow will test whether institutional investors are willing to accept the fixed price and governance structure.

Corporate governance concerns could temper enthusiasm. SpaceX plans a dual-class share structure that concentrates voting power with Musk and a small group of insiders, similar to arrangements at Tesla and other Musk-led companies. This setup prioritizes founder control but has drawn criticism from some governance advocates.

Advertisement

The listing arrives at a time when public markets are showing renewed appetite for large growth stories after years of muted mega-cap IPO activity. Strong performance by recent technology and AI-related listings has encouraged more private companies to consider going public.

SpaceX’s business spans multiple high-growth areas. Its Falcon rockets have transformed the commercial launch industry with reusable technology that dramatically lowered costs. Starlink provides high-speed internet to remote and underserved areas worldwide, with potential for significant expansion in aviation, maritime and enterprise markets. The integration with xAI adds exposure to artificial intelligence infrastructure.

Proceeds from the IPO will support continued innovation across these segments. SpaceX aims to scale Starlink’s constellation, develop next-generation vehicles including Starship, and enhance computing capabilities for AI applications.

The unconventional IPO strategy underscores Musk’s influence on capital markets. By setting a firm price ahead of the roadshow, SpaceX aims to streamline the process and avoid the volatility often seen in traditional bookbuilding. This approach has worked for Musk in past ventures and aligns with his preference for direct engagement with investors and the public.

Advertisement

Wall Street reaction has been mixed but generally positive. While some bankers note the challenges of pricing without traditional demand discovery, others see the fixed price as pragmatic given SpaceX’s visibility and strong private-market interest.

As the most anticipated IPO in years, SpaceX’s debut could set the tone for the remainder of 2026’s new issue market. Success would likely encourage other high-profile private companies to follow, potentially unlocking significant capital for growth sectors including AI, space technology and sustainable infrastructure.

For investors, the offering represents a rare opportunity to gain exposure to one of the world’s most valuable private companies. However, risks remain, including execution challenges in scaling complex technologies, regulatory hurdles in multiple jurisdictions, and dependence on Musk’s leadership and vision.

SpaceX has transformed the space industry over the past two decades, achieving milestones once considered science fiction. Its IPO marks another chapter in that evolution, bringing public market scrutiny and capital to a company long defined by ambition and innovation.

Advertisement

The coming weeks will reveal whether investors embrace SpaceX’s terms or push back on valuation and governance. With the roadshow beginning Thursday, all eyes will be on investor meetings and any adjustments to the ambitious plans.

Continue Reading

Business

NewRiver REIT plc (NRWRF) Q4 2026 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Allan Lockhart
Founder, CEO & Director

Well, good morning, everyone, and thank you for joining us. Today is really about demonstrating something quite straightforward that the strategy that we’ve been pursuing over the past few years is now translating into progress. And the operational evidence is beginning to show clearly in the numbers. FY ’26 was our first full year of benefit from the Capital Regional acquisition, and we see it as an important step forward in both scaling our platform and improving the composition of our portfolio.

Our presentation this morning is focused on 3 key things: first, how the business has performed during the year. Second, how we have repositioned the portfolio. And third, how we leverage that improved position into income growth and long-term value for shareholders.

Turning to FY ’26. We’ve delivered growth across the measures that matter most. Underlying funds from operations increased to GBP 37.2 million. Our well-covered dividend has grown to 6.7p per share, and we delivered a sector-leading 9.4% total accounting return.

Advertisement

Two things are driving this: operational delivery and capital discipline. On operational delivery, we agreed rents 37.3% ahead of the previous passing rent and 8.5% ahead of ERV. That is real pricing power across the portfolio, and it is showing through in our third consecutive period of valuation growth. On capital discipline, we have recycled assets at book value, completed a share buyback, reduced our LTV, and refinanced the balance sheet onto a fully unsecured structure.

So what we’re seeing is not simply short-term improvement, but the early evidence of a portfolio that is more focused and well positioned for income-led growth.

Advertisement
Continue Reading

Trending

Copyright © 2025